"Medical quick reading society" Xi'an yangsenguseqimab injection approved in China

[December 27, 2019 / medical information list] 352 drugs were transferred from the Beijing Medical Insurance catalogue, xinlitai invested 600 million to develop innovative products in the field of chronic diseases, Tianshi pediatric new drugs were approved, Huntington chorea drugs were listed in the domestic newspaper Daily fresh medicine news, speed reading club and you pay attention to! On July 27, the Beijing Municipal Medical Security Bureau issued a document "notice on adjusting the reimbursement scope of drugs for basic medical insurance, work injury insurance and maternity insurance in this city" According to the notice, there are 281 Western medicines and 71 Chinese patent medicines, 352 in total - 352 varieties, which have been transferred out of the Beijing Medical Insurance catalogue (Beijing Medical Insurance Bureau) Recently, Guizhou food and Drug Administration issued the notice on further standardizing the management of drug retail chain enterprises in the province, and put forward specific measures on the supervision, strengthening, expansion, operation mode and pharmacist allocation of retail drugstores It is worth noting that the retail drugstore and the hospital drugstore will be interconnected as an effective supplement to the pharmaceutical service of the hospital drugstore (Guizhou food and Drug Administration) On December 25, Sichuan Provincial Drug Administration released the 9th drug quality announcement of Sichuan Province in 2019 In the drug sampling, 26 batches of drugs were found not to meet the requirements, including 5 batches of preparations, namely, vitamin C Yinqiao Tablets, aspirin enteric coated tablets, Yuanhu Zhitong tablets; the remaining 21 batches were all Chinese herbal medicines and their pieces, including Yinyanghuo, Gansong, Xianmao, etc (Sichuan food and Drug Administration) Recently, the Shanghai Municipal Health and Health Commission issued the notice on Forwarding the first batch of national key monitoring and rational use of drugs catalogue (chemical and biological products), which put forward requirements for drug management of medical institutions in the city Among them, 20 drugs will be strictly controlled (see the medical profession) On July 27, xinlitai announced that in order to rapidly enrich the innovative product pipeline in the field of chronic diseases, Shenzhen xinlitai plans to sign an agreement with Japan Tobacco Inc to obtain the exclusive license of JT's "enarodustat" (code jtz-951) related intellectual property rights and technical information in the field of renal anemia indications in the Chinese market (cypress blue) Janssen cilag international NV's application for import registration of gusechiumab injection (trade name: tenoya) has been approved for use in adult patients with moderate to severe plaque psoriasis who are suitable for systematic treatment, the State Food and Drug Administration said Tuesday (Sina Medical News) Today, tqb3602 capsule, a new type 1 drug of Zhengda Tianqing, has been approved by clinical tacit permission for the treatment of recurrent or refractory multiple myeloma (Insight database) Tianshili announced that the exclusive paediatric new drug shaoma Zhijing granules (formerly known as Zhidong granules) has received the approval document for drug registration issued by the State Food and drug administration (meter net) On July 27, Johnson & Johnson's guselkumab injection (acceptance No.: jxss1900035) was approved by the State Food and Drug Administration for listing This product is the first McAb only for IL-23 in the world, which is used to treat adult moderate and severe plaque psoriasis (Insight database) TIWA's "deuterium butylbenzazine tablet" has been applied for listing in China by CDE for the treatment of Huntington's chorea, a rare autosomal dominant genetic disease (Insight database) Sailong Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Hunan Sailong Pharmaceutical Co., recently obtained the approval document for drug registration of tegacyclin for injection approved and issued by the State Food and drug administration, according to the announcement issued by Sailong Pharmaceutical Co., Ltd (meter net) Today, sppi announced the results of poziotinib, its exon 20 mutant EGFR inhibitor, in a phase II clinical trial called zenith20 Today, the data of the first group of patients (second-line) are released Among 115 patients, 17 have a response time of 7.4 months This is more different than the response rate of about 40% expected by investors Today, sppi is down 60% (source of us and Chinese Medicine) Green leaf Pharmaceutical Group announced Thursday that its independently developed new compound ly03005 has officially submitted a new drug listing application to FDA The drug is used to treat depression, and it is the second new central nervous drug that LVYE has declared NDA in the United States (medicine cube) Yuheng Pharmaceutical Co., Ltd announced that Guangzhou Yudong, a subsidiary company, has received the approval document for supplementary application of potassium chloride sustained release tablets approved and issued by the State Food and drug administration The drug has passed the consistency evaluation of quality and efficacy of generic drugs, and Guangzhou Yudong is the first enterprise in China to pass the consistency evaluation of the variety (meter net)